Electric Wheelchair Market Research Report - Global Forecast till 2027

 Electric Wheelchair Market

Electric wheelchairs get power from an electric motor that comes attached with the electric wheelchair. These wheelchairs offer great mobility and are light in weight. These are very compact in size and can be used in narrow pathways. The global electric wheelchair market is expecting substantial market growth during the forecast period (2019-2023). Market Research Future (MRFR) made a claim recently that the global electric wheelchair market can surpass the existing market valuation with relative ease.

Global Electric Wheelchair Market is expected to have a market value of USD 3061.64 Million by 2027.

The electric wheelchair market is expecting strong support from various pointers for a better market growth. It is expecting strong growth due to competitors participating more and more in the market to take the market ahead with their strategic moves. Its easy application is fast gaining momentum. Latest innovations are also helping the global market in its growth opportunity. However, high price and maintenance complexity can deter the global electric wheelchair market growth in the coming years.

Major Key Players:

MRFR recognizes the following companies as the Key Players in the Global Electric Wheelchair Market— GF Health Products, Inc. (US), Sunrise Medical (Germany), Quantum Rehab (US), Permobil AB (Sweden), Pride Mobility Products Corp (US), Invacare Corporation, Drive Medical (US), Ottobock (Germany), Levo AG (Switzerland), and Karman Healthcare, Inc. (US).

Segment Analysis

MRFR’s report of the global electric wheelchair market has an in-depth eye on segmentation that can impact the market in the coming years. Such a segmentation has its roots in the value-wise and volume-wise analysis of factors that can impact of the market.

Based on the electric wheelchair types, the electric wheelchair market comprises electric outdoor chair, electric indoor chair, center wheel drive chair, dual-purpose chair, front wheel drive chair, rear wheel drive chair, standing electric wheelchair, and others. The electric indoor chair segment has substantial market coverage. In many countries, lack of outdoor infrastructure can put some restraints on the expected market growth.

Based on the end-use, the electric wheelchair market comprises home care settings, hospitals/clinics, and others. The home care settings market is gaining remarkable coverage with many patients are looking for recovery from such setups.

Regional Analysis

Global Electric Wheelchair Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019. The technological advancement in the electric wheelchair with attachment of gadgets for control and accessibility majorly drive the market growth. Also, the rise in purchasing power, increasing geriatric population, and inclination towards more refined technology have been driving the progress of the electric wheelchair market in the region.

The European electric wheelchair market has been further segmented into Western Europe and Eastern Europe. The Western Europe electric wheelchair market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. Europe held the second-largest position in the electric wheelchair market with a market share of 29.3% in 2019 and anticipated to witness significant growth over the forecast period due to a higher number of patients and the availability of products in the region. Europe is also expected to have high growth in the electric wheelchair market, owing to the rising number of physically challenged people in the region.

Asia Pacific is anticipated to register the highest growth rate with a CAGR value of 8.5% over the forecast period from 2020 to 2027. According to the United Nations, across Asia, the number of people age 65 and above is expected to grow dramatically over the next 50 years. Moreover, the increasing disposable income of middle-class families, which accounts for a large population in Asia, encouraging them to spend more on health, is driving the growth of the electric wheelchairs market in the region.

The Middle East & Africa electric wheelchair market is segmented into the Middle East and Africa. The growth of the electric wheelchair market in the Middle East and Africa is growing steadily in the past few years. Increasing the prevalence of orthopedics disorders and funding by private players and government bodies is propelling the market growth in this region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Sepsis Diagnostics Market Research Report- Forecast till 2027

 Sepsis Diagnostics Market

The development of diagnostic tools for a diverse range of ailments has facilitated the development of the sepsis diagnostic market as well. Market reports connected with healthcare industry have been offered by Market Research Future which creates reports on other industry verticals that intends to analyze the current market scenarios better. The sepsis diagnostics market is on track to attain an 8 % CAGR while earning USD 710 million in the forecast period.

The severity of the symptoms of sepsis necessitate the availability of accurate tests that can detect the ailment at the initial stages. The sepsis diagnostic market is expected to be motivated by the escalating level of investments from industry players. The enhanced collection of patient outcome information and incorporation into medical records is anticipated to additionally inspire the expansion of the sepsis diagnostic market in the forecast period.

Major Key Players:

The prominent competitors in the sepsis diagnostic market are EKF Diagnostics (UK), T2 Biosystems, Inc. (US), bioMérieux, Inc. (US), Becton, Dickinson and Company (US), Sandstone Diagnostics, Inc. (US), Immunexpress (US), Axis-Shield Diagnostics Ltd. (Scotland), Cube Dx GmbH (Austria), and others.

Segment Analysis

The segmental analysis of the sepsis diagnostics market has been carried out on the basis of technology, product type, end-user, and region. Based on technology, the sepsis diagnostic market consists of biomarkers, molecular diagnostics, immunoassays, and sepsis therapeutics market, others. By type of products, the sepsis market is segmented into instruments, kits, blood culture media, and others. Based on end users, the sepsis diagnostic market is segmented into specialty clinics, hospitals, pathology laboratories, diagnostic centers, and others. The regions that are considered in the sepsis diagnostic market are the Americas, Europe, Asia Pacific, Middle East, and Africa.

Regional Analysis

The region-based study of the sepsis diagnostic market includes regions such as Americas, Europe, Asia Pacific, Middle East, and Africa. The North American region is the major market for medical tourism which is expected to motivate the development of the sepsis market in the forecast period. The North American market for sepsis diagnostics is anticipated to achieve USD 320 million by the end of the forecasted period. The European region is the next prime market for sepsis diagnostics which is anticipated to develop at the CAGR of 6.8%. While the Asia Pacific region is anticipated to be the most rapidly growing region in sepsis diagnostics market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Renal Dialysis Market 2022: Size, Share, Analysis and Forecast-2027

 Renal Dialysis Market

Renal dialysis market is likely to touch USD 26.6 Billion at an impelling 7.1% CAGR during the assessment. Dialysis has turned into a key growth field as different forms of kidney diseases especially diabetes has exploded. Diabetes is the seventh leading cause of death. Dialysis is a means of removing waste products such as creatinine and urea from the blood owing to inappropriate kidney functioning and generally needed for those with chronic renal failure. This process is used for purifying the blood, removing excess toxins and fluid and restoring the electrolyte balance in the blood.

There are many factors that can be linked to the growth of renal dialysis market. Some of the market trends and factors in this market as per an analysis conducted by Market Research Future (MRFR) include increase in diabetes rate, large patient base of renal dialysis, lack of donors for kidney transplant, evolution of dialysis technology, overall growth of the healthcare sector, advances in renal dialysis equipment procedures and increasing number of patient suffering from hypertension and diabetes. On the flip side, there are a couple of factors that is likely to restrict the growth of the renal dialysis market such as high prices related to dialysis, complications post treatment, fall in Medicare reimbursements, manufacturers having pricing pressure from the government, product recalls, low awareness regarding kidney disease treatment modalities and reuse of the hemodialysis consumables.

Major Key Players:

Leading players profiled in the renal dialysis manufacturers include NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Nikkiso Co. Ltd. (Japan), Covidien (Ireland), Covidien (Ireland), Diaverum Deutschland GmbH (Germany), Nipro diagnostic Inc. (US), Nipro diagnostic Inc. (US), Gambro AB (Sweden), Medical Care AG & Co.,), B.Braun Melsungen AG (Germany), DaVita Healthcare Partners Inc. (US), Fresenius Medical Care (German) and Baxter International Inc. (US).

Market Segmentation

Market Research Future report provides a comprehensive segmental analysis of the renal dialysis market on the basis of types, product and end user.

Based on type, it is segmented into primary and secondary dialysis. Primary dialysis is further segmented into peritoneal dialysis, hemofiltration and hemodialysis and secondary dialysis is further segmented into intestinal dialysis and hemodiafiltration.

Based on product, the renal dialysis market is segmented into peritoneal dialysis products and hemodialysis products. Of these, the hemodialysis products grab a higher market share.

Based on end user, it is segmented into home care and hospital care. Of these, home care has a higher share in the renal dialysis market.

Regional Analysis

Based on region, the renal dialysis market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America leads the renal dialysis market due to rising presence of large patient base having renal diseases in this region. Europe and Asia Pacific have similar market share but the APAC market is likely to grow relatively higher during the forecast period. The Middle East and African market possess a minimal share in the renal dialysis market and is predicted in exhibiting a limited growth during the forecast period.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Ureteral Stents Market – Industry Share Report 2022

 Ureteral Stents Market

Ureteral stents are hollow & thin tubes that are inserted in ureters to treat or prevent obstacles during ‘urine-flow.’ They find applications in urological surgeries for retaining ureter patency & ensuring proper urinary-drainage. Ureteral stents are employed by the right end-users through various endourological procedures. They are mainly inserted with the help of cytoscopes. Multiple factors; like kidney stones, prostate cancers, and pre-operative patients draw the adoption of ureteral stents.

These stents enable the transport of remaining fragments without causing obstructions. Stents are also used for scratched ureters. Frankly, any kind of ureter surgery normally involves stents for ureter-treatments. Some other propellers of the ureteral stents market include tumors, bladder irregularities, & ureteral scarring/narrowing. With a rise in such cases, the global ureteral stents market is set to grow at a substantial CAGR in the forecast period.

Major Key Players:

 The market players playing a great role in the market include Boston Scientific of the United States, Brightwater Medical of the United States, Cook Medical of the United States, Merit Medical System Inc. of the United States, C. R. Bard of the United States, Medline Industries Inc. of the United States, B. Braun of Germany, Biometrics of Italian region, Olympus of Japanese region, Teleflex Incorporated of the United States region, Coloplast of Denmark, Allium Medical of Israel and many others. Their strategies so put forward helps in analyzing the competitive ureteral stents market outlook. 

Propellers & Drawbacks

The ureteral stents market is mainly driven by all medical conditions that need these tubes. The world is experiencing a rise in kidney stones, because of certain factors. These factors encompass regular consumption of alcohol, animal proteins, calcium, vitamin supplements, etc. Of the different ‘kidney-stone’ treatments available, ureterorenoscopy & ureteroscopy observe the widest adoption of these stents, thereby driving the stents manufacturer industry.

Alongside, kidney transplants propel market demand. All kidney replacement surgeries require ureteral stents inside the human body, till patients adjust to their new kidneys. Infection, dislocation, & obstruction complexities may result from the adoption of urinary stents, negatively impacting the market. Also, patients could experience discomfort or other problems while passing urine. All these factors urge research & development firms to create new products, slowing down the market.

Inactive lifestyles and aging population are important contributors to urinary disorders. Thus, both of them add to the usage of these stents, promoting market sales. Other factors affecting the market comprise unhealthy food, metabolic disorders, obesity, and dehydration. Novel smartphone applications are advantageous for doctors & patients, raising market expansion. Other hindrances that prevent further industry-progress are scarcity of proficient doctors and intricacies across extractions & placements.  

Regional Analysis

The worldwide market is classified into materials, kinds, applications, and regions. Silicon, metal, hydrogel, plastic, polyurethane, etc. form the materials. The kinds encompass closed end, double pigtail, open end, and multiloop. Based on applications, the market consists of lithotripsy, ureterorenscopy, and others. Latin America, North America, Eastern Europe, Asia Pacific, Western Europe, and the Middle East & Africa constitute the geographies.

Emerging markets, such as Europe and North America are predicted to undergo swift expansion. Their increasing participants, research & developments, and urology incidences drive their sales. Asia Pacific would observe decent trends, as a consequence of its expanding medical infrastructure & supportive ‘patient-demographics.’  Asia Pacific is home to even more patients suffering from these diseases. With better fiscal conditions in India, China, and Brazil; majority of the business expansion could be ascribed to the collective demand from these nations. The Middle East specializes in advanced urology services.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Artificial Cervical Disc Market | Global Market Synopsis & Forecast – 2027

 Artificial Cervical Disc Market

The global artificial cervical disc market is driven by several factors, such asthe increasing prevalence of orthopedic diseases and degenerative diseases, technological advancements in artificial discs, and the rise of a geriatric population in developed and developing economies.

According to MRFR analysis, the global artificial cervical disc market is expected to register a CAGR of ~19% from 2021 to 2027 and hold a value of ~USD 6,262.1 million by 2027.

In addition, the artificial cervical disc market is anticipated to grow during the forecast perioddue to the rising healthcare expenditure, supportive reimbursement, growing acceptance of implantation, increasing disposable income, and increasing investments in healthcare infrastructure by the government and private sectors.

Major Key Players:

Some of the key players in the global artificial cervical disc market are Globus Medical Inc (US), Zimmer Biomet Holdings Inc. (US), B. Braun Melsungen AG (Germany), Centinel Spine, LLC (Switzerland), Medtronic PLC (Ireland), Nuvasive Inc. (US), Johnson & Johnson (US), Orthofix Company (US), Alphatec Spine (US), Simplify Medical (US), AxioMed (US), Aditus Medical (Germany), FH Orthopedics (France), Medicrea (France), and Spineart (Switzerland)

Segment Analysis

The artificial cervical disc market is segmented on the basis of artificial cervical disc types, material, end user, and region.

Based on product type, the artificial cervical disc market is categorized into cervical disc and lumbar disc. The cervical disc segment held a significant market share in 2020.The rising prevalence of degenerative disc disease and the growing demand for non-invasive procedures are the key driving factors of the artificial cervical disc segment.

Based on material, the artificial cervical disc market is classified into metal-on-metal and metal-on-biopolymer. The metal-on-metal material segment is expected to attain significant revenue over the forecast period. Growing preference for metal implants by Numerous healthcare practitioners, including surgeons, doctors, and clinicians.Moreover, metal implants requires considerably lower costs than metal-on-biopolymers.

Based on enduser, the artificialcervical disc market can be segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment was the largest end usersegment in 2020 due to the availability of skilled doctors, high efficacy rate, better treatment, and advancements in the hospital infrastructure.

In terms of geography, the artificialcervical disc market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World.North America held the largest market share in 2020 due to the increasing geriatric population, higher success rate of artificial disc replacement surgery in this region, and growing awareness among the patients about the availability of various treatment options. Furthermore, Asia-Pacific is projected to be the fastest-growing regional market during the forecast period due to factors such as a large customer base, high prevalence of orthopedic diseases, degenerative spine conditions, and improving healthcare infrastructure.According to the WHO, by 2050, 130 million people will suffer from osteoarthritis worldwide, of whom 40 million will be severely disabled by the disease.

Regional Analysis

On a regional basis, North America is anticipated to dominate theglobal artificial cervical disc market due tothe major market players involved in R&D activity,a higher success rate of artificial disc replacements, rising healthcare expenditurein the region, and improving economy.In addition, the presence of the major giants in the market involved in merger &acquisition and new product innovation is another driving the market growth. For instance,in January 2018, Nuvasive Inc. (US)acquired Safe PassageNeuromonitoring LLC(US)to strengthen its intraoperative neurophysiological monitoring (IONM) business line.

On the other hand, Europe is expected to hold the second-largest position in the global artificial cervical disc market due to investment in healthcare.Technological advancements in surgical techniques and materials have led to an increased demand for artificial cervical disc.

Furthermore, artificial cervical disc replacement in Europe will turn out to be one of the most sought-after medical procedures by medical tourists. Cost-effective and excellent medical care offered by the European spine surgeons and increasing investment in the R&D sector isalso fueling the market growth in this region.

Asia-Pacificis projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on health care, large population, improving economy, and growing medical tourism in developing nations such as China, Japan, and India in this region.

Furthermore, the growth of the market in theRest of the World is attributed to rapidly improving healthcare infrastructure, technological development,healthcare management, and hospital management.Government initiatives for improving the healthcare sector are another factor boosting the growth of the market in this region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Remdesivir Market - Global Industry Size, Share, Analysis and Forecast 2022 – 2027

 Remdesivir Market

Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly.

The growth of the global Remdesivir (COVID 19) market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to the outbreak of COVID-19 globally. Furthermore, the rising geriatric population is also expected to fuel market growth during the forecast period. However, the availability of various substitutes for Remdesivir (COVID 19), are expected to restrain the growth of the global Remdesivir (COVID 19) market.

According to MRFR analysis, Global Remdesivir (COVID 19) Market is expected to register a CAGR of 31.2% during the forecast period of 2020 to 2027 and reach USD 10,119.99 Million by 2027.

Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Cipla, Pfizer, Merck, Cayman Chemical, Kelun Pharma, Hunan Warrant Pharmaceutical, Dr. Reddy's Laboratories, and others are some of the major market leaders in Remdesivir. Organic strategies such as product launches, mergers, and collaborations are used by the companies operating on the market to boost their share. Gilead Sciences, Inc., for instance, has announced it will donate 1.5 million doses of the medication for compassionate use. The company has also started manufacturing liquid and freeze-dried ways to improve supplies. UK-based AstraZeneca has approached rival drug maker Gilead Sciences about a potential merger.

Major Key Players:

Some of the key players in the global remdesivir (COVID 19) market are Gilead Sciences, Inc. (US), Mylan (US), Cipla (India), Hetero Labs (India), and Jubilant Life Sciences (India)

Segment Analysis

Global Remdesivir (COVID 19) market has been segmented based on the Dosage and Distribution Channel.

Based on the dosage, the global remdesivir (COVID 19) market has been segmented into 5mg, 10mg, 50mg, and 100mg. The 100 mg segment is expected to hold the largest market share owing to rise in COVID 19 and 100 mg is specifically used for older people and COVID 19 is affecting more in older people

On the basis of distribution channel, the market has been segmented into hospitals and drug stores. The hospitals are expected to hold a major market share owing to government regulation i.e. the drug can be given in the hospitals only.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2020, owing to the growing cases of COVID 19 in the region. The remdesivir (COVID 19) market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European remdesivir (COVID 19) market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The remdesivir (COVID 19) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing rate of COVID 19 cases, the market in Asia-Pacific is expected to be the fastest-growing. The remdesivir (COVID 19) market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Thalassemia Treatment Market Forecast to 2027 Available in New Report

 Thalassemia Treatment Market

Thalassemia is an inherited blood disorder that is characterized by inadequate hemoglobin and fewer red blood cells in the body than normal. Hemoglobin is the substance in red blood cells that allows them to carry oxygen. The inadequate hemoglobin and fewer red blood cells of thalassemia may cause anemia.

According to MRFR analysis, Thalassemia Treatment Market is expected to register a CAGR of 10.4% during the forecast period and was valued at USD 1890.4 Million in 2018.

The growth of the Global Thalassemia Treatment Market is driven by various factors such as rising incidence of thalassemia, increasing pipeline drugs in thalassemia, rise in awareness regarding available treatment options for the treatment of thalassemia, growing public awareness related to preventive care and rise in demand for improved curative gene therapy. However, stringent regulatory policies and high treatment costs are expected to curb the growth of the global thalassemia treatment market.

The global thalassemia treatment market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the Key Players in the Global Thalassemia Treatment Market are Novartis AG (Switzerland), Kiadis Pharma (Netherlands), Sangamo Therapeutics (US), Gamida Cell (Israel), Acceleron Pharma, Inc. (US), CELGENE CORPORATION (US), and Bluebird Bio, Inc. (US).

Segment Analysis

The Global Thalassemia Treatment Market has been segmented based on type, treatment, and end-user.

The market, based on type, has been divided into alpha-thalassemia and beta-thalassemia. The alpha-thalassemia segment is likely to be the fastest during the forecast period as there is an increased incidence of alpha-globin disorders in the US and other Western nations.

The global thalassemia treatment market has been segmented based on treatment, into blood transfusions, iron chelation therapy, folic acid supplements, thalassemia gene therapy, and bone marrow transplants. The blood transfusions segment is expected to be the fastest market as low risks are involved due to careful blood screening. For instance, about 56,000 population have major thalassemia, and there are at least 30,000 people that need regular blood transfusions to survive and 5,500 die perinatally due to alpha-thalassemia major. As a result, increasing the need for blood transfusions would boost the growth of the thalassemia treatment market.

The end-user segment of the market includes hospitals and clinics, diagnostic laboratories, and others. The hospitals and clinics segment is expected to hold the largest share of the market due to the increase in the number of hospital admissions for the treatment of thalassemia across the globe.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of thalassemia and rising per capita healthcare expenditure. The thalassemia treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European thalassemia treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The thalassemia treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Increasing government initiatives to promote the thalassemia treatment technique is expected to boost the growth of the thalassemia treatment market in Asia-Pacific and is expected to be the fastest-growing. The thalassemia treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Antibiotic Resistance Market Forecast to 2027 Detailed in New Research Report

 Antibiotic Resistance Market

Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs. Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic.

According to MRFR analysis, Antibiotic Resistance Market is expected to register a CAGR of 5.8% during the forecast period and was valued at USD 8,120 Million in 2018.

The growth of global antibiotic resistance market is driven by various factors such as -      Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistance

Several market players currently dominate the global antibiotic resistance market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the Key Players in the Global Antibiotic Resistance Market are Achaogen, Inc. (US), MELINTA THERAPEUTICS, INC. (US), Nabriva Therapeutics plc (Ireland), PARATEK therapeutics (US), Seres Therapeutics (US), Theravance Biopharma (UK), Tetraphase Pharmaceuticals (US), Basilea Pharmaceutica Ltd. (Switzerland), Entasis Therapeutics (US), NEMESIS BIOSCIENCE LTD (UK), Procarta Biosystems (England), and Allecra Therapeutics (US)

Segment Analysis

The Global Antibiotic Resistance Market has been Segmented Based on Drug Class, Disease, Pathogen, and End User.

The market, based on drug class, has been divided into cephalosporins, Combination therapies, tetracyclines, lipoglycopeptides, oxazolidinones, and others. The combination therapies segment is likely to be the largest growth during the review period due to the increased usage of these therapies for gram-negative infections. Additionally, it has minimal treatment options available with the increasing demand for antibiotic resistance, thus driving the growth of this segment.

The global antibiotic resistance market has been bifurcated, based on disease, into complicated urinary tract infections, bloodstream infections, complicated intra-abdominal infections, clostridium difficile infections, acute bacterial and skin structure infections, hospital-acquired bacterial pneumonia/ventilator, community-acquired bacterial pneumonia, and others. The complicated urinary tract infections segment is expected to hold the majority share of the market as urinary tract infections (UTIs) are one of the most common types of infections. Additionally, there were around 1,045 patients affected by UTI.

The global antibiotic resistance market has been segmented based on pathogen into staphylococcus aureus, streptococcus pneumoniae, antibiotic resistant bacteria, acinetobacter, enterococcus, Hemophilus influenzae, pseudomonas aeruginosa, clostridium difficile, K. pneumoniae, campylobacter, and others. K. pneumoniae is expected to be the fastest segment owing to the increasing K. pneumoniae. Moreover, there were around 212,500 infection cases per year and about 70 deaths every year which would eventually drive the growth of the antibiotic market in this segment.

The end user segment of the antibiotic resistance market includes hospitals & clinics, research organizations, and others. The hospitals & clinics segment is expected to hold the largest share of the market as the majority of treatments and procedures are carried out in hospitals, which ultimately increases the usage of antibiotic resistance drugs in the antibiotic resistance market. As a result, this drives the growth of the antibiotic resistance market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising growth in the pharmaceutical sector. The antibiotic resistance market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European antibiotic resistance market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The antibiotic resistance market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Increasing healthcare expenditure has boosted the growth of the antibiotic resistance market; the market in Asia-Pacific is expected to be the fastest-growing. The antibiotic resistance market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Uveitis Treatment Market report predicts impressive growth by 2027 just published

 Uveitis Treatment Market

Uveitis is an inflammation that occurs in the uvea. It is found in people aged between 20 to 50. Based on the origin of inflammation, uveitis categories in major three types, namely, anterior uveitis, posterior uveitis, and intermediate uveitis.

The growth of the global uveitis treatment market is determined by numerous factors such as increasing research & development (R&D) expenditure, rising prevalence of uveitis and continuous product launches. However, side-effect related to corticosteroid drugs is projected to restrain the growth of the market during the forecast period.

According to MRFR analysis, Uveitis Treatment Market is expected to register a CAGR of 5.6% during the forecast period and was valued at USD 534.6 million in 2018.

The global uveitis treatment market is currently dominated by several market players. The key players are involved in expansion, product launches, and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the key players in the Global Uveitis Treatment Market are Allergan PLC, Novartis AG, Bausch Health, EyePoint Pharmaceuticals, Inc., AbbVie Inc., Horizon Therapeutics PLC, Mylan N.V., and Alimera Sciences.

Segment Analysis

The global uveitis treatment market has been segmented based on type, drug class, and end-user.

The market, based on type, has been divided into anterior uveitis, intermediate uveitis, , posterior uveitis treatment and others. The anterior uveitis is likely to hold maximum market share in the global uveitis treatment market.

The global uveitis treatment market based on drug class has been segregated into corticosteroid drugs, anti-inflammatory drugs, immunosuppressive drugs, and others. The corticosteroids drugs segment is anticipated to hold the largest share in the market due to the rising preference in the treatment of uveitis.

The end-user segments of the market are hospitals, specialty clinics, and others. The hospital's segment is expected to hold the largest share of the market, as these are the primary locations where patients receive treatment.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are anticipated to hold the largest market share owing to the increasing prevalence of uveitis, the presence of a well-established healthcare sector, and high R&D expenditures. The uveitis treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

The European uveitis treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The uveitis treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the presence of a large patient pool and expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest-growing. The uveitis treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Vision Care Market, Size, Share, Growth, Business Risk & Industry Analysis Reports 2027

 Vision Care Market

Vision care plays an essential role in ophthalmology. The vision care products and procedures are used for treating the indications. For instance, the prevalence of vision impairment is about 1,000 million cases globally. The vision care has benefited resolve ophthalmic disorders and diseases.

According to MRFR analysis, Vision Care Market is expected to register a CAGR of 4.48% during the forecast period was valued at USD 52,000 Million in 2018.

However, unawareness about the vision care products and services is likely to hamper the growth of the global vision care market during the forecast period.

Several market players currently dominate the global vision care market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the key players in the Global Vision Care Market are Cadila Healthcare (Zydus Pharmaceuticals, Inc.), Johnson & Johnson Services, Inc., Rayner Surgical Group Limited (Rayner Intraocular Lenses Limited), Menicon, Carl-Zeiss-Stiftung (Carl Zeiss). ESSILORLUXOTTICA, Bausch Health (Bausch & Lomb Incorporated), The Cooper Companies, Inc (Cooper Vision), NOVARTIS AG.

Segment Analysis

The global eye market has been segmented based on product type, indication, treatment, and end user.

The market, based on product type, has been divided into contact lenses, eyeglasses, intraocular lenses (IOL), and others. The contact lens segment has been further classified as corrective lens, therapeutic lens, cosmetic, and lifestyle-oriented lens. The contact lens is likely to hold the maximum market share in the global vision care market, owing to the unwillingness of people to use the eyeglasses. Eyeglasses are further segmented single vision, bifocal, progressive, sunglasses. The intraocular lens (IOL) segment is further segmented into Premium, Traditional/Mono-focal, Phakic.

The global vision care market on the basis of indication has been segregated into refractive error cataract, glaucoma, diabetic retinopathy, amblyopia, dry eyes, and others.

On the basis of treatment, the global vision care market is mainly segmented into Surgery, medication, and others.

The end user segment of the market consists of eye hospitals & clinics, ambulatory surgery centers, optical stores, and others. Optical stores segment is expected to hold the largest share of the market as these centers are primary locations for patients utilize the vision care products.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced vision care procedures. The vision care market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.

The vision care market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is anticipated to hold the largest market share owing to the increasing number of increasing geriatric population and rising adoption of technological advancements in developing regions. The European vision care market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The vision care market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com